Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2016

View Archived Issues

Vyriad enters global license agreement with Stinginn

Eisai reviews accomplishments of first quarter of fiscal 2016

Merck & Co. patents BACE1 and -2 inhibitors

Sumitomo Dainippon Pharma discloses Nav1.7 channel blockers

Millennium Pharmaceuticals describes Nampt inhibitors

Scripps Research Institute develops MCT1 and/or MCT4 inhibitors

MyoKardia presents cardiac myosin activators

MMRF and University of Michigan collaborate on a new molecular profiling initiative

Autologous BMC is safe and effective in treating patients with atrophic non-unions

FDA accepts Merck & Co.'s MK-1293 NDA for review

Mylan completes public offer settlement with Meda

CheckMate 026 phase III study of Opdivo does not meet primary endpoint

ZSYM73 affibody in a mouse model of AD

Shire reports recent developments of second quarter 2016

UT Southwestern receives funding from NCI to target rising rates of kidney cancer

Hematogenix announces launch of Ventana PD-L1 (SP142) and (SP263) assays

FDA approves Merck & Co.'s Keytruda for patients with recurrent or metastatic HNSCC

Lantern Pharma to evaluate BioNumerik's Tavocept

FDA grants orphan drug designation to vedolizumab

Boehringer Ingelheim begins phase II trial of BI-425809 in patients with schizophrenia

Phase II trial of volixibat in patients with NASH recruiting patients

Tolerogenic nanoparticles improve biologic drug efficacy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...